Get startedLog in
    Picture of Alpine Immune Sciences logo

    ALPN — Alpine Immune Sciences News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapHigh Flyer
    All News

    Brief: Alpine Immune Sciences To Present Data From Ruby-1, A Phase 1 Study Of Povetacicept, At Upcoming Scientific Congresses

    Picture of Alpine Immune Sciences logoAlpine Immune Sciences
    19/05/2023 21:31
    Alpine Immune Sciences Inc  ALPN.O :
    * ALPINE IMMUNE SCIENCES TO PRESENT DATA FROM RUBY-1, A
PHASE 1
STUDY OF POVETACICEPT, AT UPCOMING SCIENTIFIC CONGRESSES

Source text for Eikon:  ID:nBw4RygDma 
Further company coverage:  ALPN.O

    Recent news on Alpine Immune Sciences

    See all news